400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2017-09-05
选择性口服免疫疗法研发商
医药研发/制造
化学&生物药
IBG Risikokapitalfonds II GmbH & Co. KG;
IBG Risikokapitalfonds II GmbH & Co. KG;
Omega Funds;
Omega Funds;
Bayern Kapital;
LifeCare Partners;
Life Sciences Partners;
Fund+
Businesswire2026-04-26
GlobeNewswire2026-04-26
GlobeNewswire2026-04-26
Businesswire2026-04-26
PRNewswire2026-04-26
PRNewswire2026-04-26
PRNewswire2026-04-25
GlobeNewswire2026-04-25
GlobeNewswire2026-04-25
GlobeNewswire2026-04-25